Stimulus-response and Parkinson's Disease (SRlearning) (SRlearning)
Primary Purpose
Parkinson's Disease
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Stimulus-response
Sponsored by
About this trial
This is an interventional basic science trial for Parkinson's Disease
Eligibility Criteria
Inclusion Criteria:
- Patient : Parkinson's disease Controls: healthy volunteers paired to patients on sex and age group
Exclusion Criteria:
- Other neurological condition
- Known pregnancy or breastfeeding woman
- No medical insurance coverage
- Person under legal protection
Sites / Locations
- Fondation Ophtalmologique A. de Rothschild
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Parkinson's disease
Controls
Arm Description
Parkinson's disease patients
Healthy volunteers paired with Parkinson's disease patients on sex and age group, whose data will be extracted from a CNRS existing database
Outcomes
Primary Outcome Measures
Reaction time (second)
Secondary Outcome Measures
Full Information
NCT ID
NCT02515136
First Posted
July 30, 2015
Last Updated
December 20, 2019
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
1. Study Identification
Unique Protocol Identification Number
NCT02515136
Brief Title
Stimulus-response and Parkinson's Disease (SRlearning)
Acronym
SRlearning
Official Title
Stimulus-response Associations in Parkinson's Disease Patients
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Terminated
Study Start Date
July 1, 2015 (Actual)
Primary Completion Date
January 2018 (Actual)
Study Completion Date
January 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In a computerized experiment, visual stimuli will be presented to the parkinson's disease patients and to the controls. They will respond to each image by acting on the keyboard in a specific manner. Each participant will repeat that task 384 times per session. A break will be inserted every 12 tests so that participants can rest.
The experiment consists of three sessions. Each image will be presented three times. For the first two presentations it is assumed that a link will be created between the image and the task, and the image and action. In the third presentation, the same task and the same action will be maintained or will be swapped. In this way, It can be checked whether associations thus generated will affect the performance of the participants when tasks and actions will be incongruent.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson's Disease
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Parkinson's disease
Arm Type
Experimental
Arm Description
Parkinson's disease patients
Arm Title
Controls
Arm Type
Other
Arm Description
Healthy volunteers paired with Parkinson's disease patients on sex and age group, whose data will be extracted from a CNRS existing database
Intervention Type
Behavioral
Intervention Name(s)
Stimulus-response
Intervention Description
See summary
Primary Outcome Measure Information:
Title
Reaction time (second)
Time Frame
immediate
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patient : Parkinson's disease Controls: healthy volunteers paired to patients on sex and age group
Exclusion Criteria:
Other neurological condition
Known pregnancy or breastfeeding woman
No medical insurance coverage
Person under legal protection
Facility Information:
Facility Name
Fondation Ophtalmologique A. de Rothschild
City
Paris
ZIP/Postal Code
75019
Country
France
12. IPD Sharing Statement
Learn more about this trial
Stimulus-response and Parkinson's Disease (SRlearning)
We'll reach out to this number within 24 hrs